Bisphenol A

Bisphenol A

SCHEMBL29388682

C=CC(=O)O.CC(C)(c1ccc(O)cc1)c1ccc(O)cc1.OCCCO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 9/20 0.52
ESR2 Q92731 9/20 0.52
CYP3A4 P08684 3/20 0.52
ESRRG P62508 3/20 0.52
AR P10275 1/20 0.52
HPGD P15428 1/20 0.52
TSHR P16473 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A4 P31645 1/20 0.52
HTR6 P50406 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ALDH1A1 P00352 4/20 0.50
LMNA P02545 2/20 0.38
TYR P14679 1/20 0.38
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
GAA P10253 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bisphenol A SCHEMBL29368155 0.93 ESR1 (0.55) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL8816213 0.90 ESR1 (0.64) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL21433064 0.90 ESR1 (0.64) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL30655322 0.90 ESR1 (0.64) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL11197217 0.87 ESR1 (0.42) ESR1ESR2CYP3A4ESRRGAR
Acrylic Acid SCHEMBL813585 0.85 ALDH1A1 (0.71) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL11197214 0.83 ESR1 (0.47) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL30500338 0.82 ESR1 (0.46) ESR1ESR2CYP3A4ESRRGAR
Bisphenol A SCHEMBL28315209 0.81 ESR1 (0.67) ESR1ESR2CYP3A4ESRRGAR
Acrylic Acid SCHEMBL30803811 0.79 ESR1 (0.61) ESR1ESR2CYP3A4ESRRGAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2026-02-12 US claimed
WO-2025198684-A9 BaTiO3 NANOCRYSTALS AND NANOCOMPOSITES PIXELLIGENT TECHNOLOGIES LLC (US) 2025-11-27 WO claimed
US-12466899-B2 Binder compositions and uses thereof KNAUF INSULATION SPRL (BE) 2025-11-11 US claimed
US-12215039-B2 Synthesis, capping, and dispersion of TiO2 nanocrystals PT SPE SUBCO LLC (US) 2025-02-04 US claimed
US-11945883-B2 Binder compositions and uses thereof KNAUF INSULATION SPRL (BE) 2024-04-02 US claimed
EP-3368593-B1 IMPROVED BINDER COMPOSITIONS AND USES THEREOF KNAUF INSULATION SPRL (BE) 2023-12-06 EP claimed
US-20220306769-A1 Binder Compositions and Uses Thereof KNAUF INSULATION SPRL (BE) 2022-09-29 US claimed
US-11430984-B2 Electrodes including a passivation layer THE JOHNS HOPKINS UNIVERSITY (US) 2022-08-30 US claimed
US-11378885-B2 Pattern formation material and pattern formation method KIOXIA CORPORATION (JP) 2022-07-05 US claimed
US-11325985-B2 Binder compositions and uses thereof KNAUF INSULATION SPRL (BE) 2022-05-10 US claimed
WO-2026106028-A1 ELECTROLYTE MEMBRANE AND METHOD FOR MANUFACTURING SAME 더블유스코프코리아 주식회사 2026-05-21 WO disclosed
EP-4740970-A2 MULTI-LAYERED BIOMIMETIC OSTEOCHONDRAL IMPLANTS Hyalex Orthopaedics, Inc. (US) 2026-05-13 EP disclosed
EP-4362856-B1 MULTI-LAYERED BIOMIMETIC OSTEOCHONDRAL IMPLANTS HYALEX ORTHOPAEDICS INC (US) 2026-05-06 EP disclosed
US-20260092135-A1 POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF UMICORE NV (BE) 2026-04-02 US disclosed
US-20260094823-A1 COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL UMICORE NV (BE) 2026-04-02 US disclosed
US-11378885-B2 Pattern formation material and pattern formation method KIOXIA CORPORATION (JP) 2022-07-05 US disclosed
US-11325985-B2 Binder compositions and uses thereof KNAUF INSULATION SPRL (BE) 2022-05-10 US disclosed
EP-2753649-B1 POLYMERIZABLE COMPOSITIONS CONTAINING (METH)ACRYLATE MONOMERS HAVING SULFIDE LINKAGES PPG IND OHIO INC (US) 2022-03-09 EP disclosed
US-20220050256-A1 COLORED RIBBON WITH DISCRETE COLOR LAYERS CORNING RESEARCH & DEVELOPMENT CORPORATION 2022-02-17 US disclosed
EP-3948380-A1 COLORED RIBBON WITH DISCRETE COLOR LAYERS Corning Research & Development Corporation (US) 2022-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042870-A1 BINDER COMPOSITIONS AND USES THEREOF SMCHD1, VCL, FGB ESR1 3514/4885ESR2 4338/4885CYP3A4 2949/4885
US-20260094823-A1 COMPOSITE CATHODE COMPRISING A POLYMER ELECTROLYTE AND NICKEL BASED CATHODE ACTIVE MATERIAL NES, HCN2, HCN1 ESR1 917/4885ESR2 1857/4885CYP3A4 2700/4885
US-20260092135-A1 POLYMER ELECTROLYTE COMPRISING A POLYACRYLAMIDE AND METHODS FOR THE PRODUCTION THEREOF RPL6, EFNA1, HCN1 ESR1 572/4885ESR2 2603/4885CYP3A4 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.